Par Drugs & Che.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: INE04LG01015
  • NSEID: PAR
  • BSEID:
INR
82.47
-0.16 (-0.19%)
BSENSE

Apr 02

BSE+NSE Vol: 7616

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.37% vs 10.02% in Sep 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 16.22% vs 24.02% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -0.16% vs 70.51% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -80.00% vs 150.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Par Drugs & Che. With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
29.34
0
29.34
Other Operating Income
0.00
0.00
0.00
Total Operating income
29.34
0
29.34
Raw Material Cost
12.12
0
12.12
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.27
0
0.27
Employee Cost
1.41
0
1.41
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
9.48
0.00
9.48
Total Expenditure (Excl Depreciation)
23.28
0
23.28
Operating Profit (PBDIT) excl Other Income
6.06
0.00
6.06
Other Income
1.33
0
1.33
Operating Profit (PBDIT)
7.39
0
7.39
Interest
0.01
0
0.01
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
7.38
0
7.38
Depreciation
0.93
0
0.93
Profit Before Tax
6.44
0
6.44
Tax
1.64
0
1.64
Provisions and contingencies
0.00
0
0.00
Profit After Tax
4.80
0
4.80
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
4.80
0
4.80
Equity Capital
12.30
0
12.30
Face Value
10.00
0
0.00
Reserves
98.83
0
98.83
Earnings per share (EPS)
3.90
0
3.90
Diluted Earnings per share
3.90
0
3.90
Operating Profit Margin (Excl OI)
20.65%
0%
0.00
20.65%
Gross Profit Margin
25.15%
0%
0.00
25.15%
PAT Margin
16.36%
0%
0.00
16.36%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 29.34 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2.37% vs 10.02% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 37.23% vs -10.92% in Dec 2024

Quarterly - Standalone Net Profit
Standalone Net Profit 4.80 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 16.22% vs 24.02% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 727.59% vs -83.04% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.06 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -0.16% vs 70.51% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 326.76% vs -72.85% in Dec 2024

Quarterly - Interest
Interest 0.01 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -80.00% vs 150.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.65%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024